Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Stomach Neoplasms 1Pancreatic Neoplasms 1Liver Neoplasms 1Hemorrhage 1Colonic Neoplasms 1

Interventions

Gemcitabine 16Fluorouracil 6Irinotecan 4Cisplatin 4Capecitabine 4Oxaliplatin 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3nimotuzumab 2Taxes 2Phytotherapy 2Leucovorin 2Drug Therapy 2surufatinib 1rubitecan 1racemetyrosine 1pertuzumab 1pembrolizumab 1methylnaltrexone 1folfirinox 1cyclopropapyrroloindole 1camrelizumab 1Trastuzumab 1Tranexamic Acid 1Standard of Care 1Sirolimus 1Radiotherapy 1Positron Emission Tomography Computed Tomography 1Phenytoin 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Pancreatic Neoplasms × Tranexamic Acid × Clear all
NCT01655641 2012-10-16

TMGS

Tribhuvan University Teaching Hospital, Institute Of Medicine.

Phase 2/3 Unknown
118 enrolled
Gastrointestinal

Colonic Neoplasms, Hemorrhage, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡